Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 2, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc.
| 350K |
—
|
—
|
∞
| 350K | +2 |
Jun 28
| ||||||
Akebia Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +2 | |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +44.33% | 97.68K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +31.50% | 125.23K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +31.24% | 126.03K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +34.43% | 117.13K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +68.65% | 73.7K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +68.65% | 73.7K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +22.26% | 164.8K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| -12.02K |
$1.26 | -$15,140.16 | -1.81% | 651.24K | +1 |
May 13
| ||||||
Akebia Therapeutics, Inc.
| -34.84K |
$1.26 | -$43,898.40 | -4.93% | 672.09K | +1 |
May 13
| ||||||
Akebia Therapeutics, Inc.
| -27.00K |
$1.15 | -$31,050.00 | -3.88% | 668.84K | +1 |
Aug 25
| ||||||
Akebia Therapeutics, Inc.
| -8.66K |
$1.58 | -$13,684.38 | -1.21% | 706.93K | +1 |
Feb 29
| ||||||
Akebia Therapeutics, Inc.
| -5.97K |
$1.58 | -$9,438.92 | -0.89% | 663.26K | +1 |
Feb 29
| ||||||
Akebia Therapeutics, Inc.
| -46.57K |
$1.58 | -$73,580.60 | -2.23% | 2.04M |
Feb 29
| |||||||
Akebia Therapeutics, Inc.
| -7.17K |
$1.58 | -$11,327.02 | -1.02% | 695.84K | +1 |
Feb 29
| ||||||
Akebia Therapeutics, Inc.
| -7.41K |
$1.52 | -$11,264.72 | -1.10% | 669.23K | +1 |
Feb 27
| ||||||
Akebia Therapeutics, Inc.
| -10.74K |
$1.52 | -$16,330.88 | -1.48% | 715.59K | +1 |
Feb 27
| ||||||
Akebia Therapeutics, Inc.
| -8.37K |
$1.52 | -$12,717.84 | -1.18% | 703.01K | +1 |
Feb 27
| ||||||
Akebia Therapeutics, Inc.
| -37.73K |
$1.52 | -$57,354.16 | -1.77% | 2.09M |
Feb 27
| |||||||
Akebia Therapeutics, Inc.
| 303.3K |
—
|
—
|
∞
| 303.3K |
Jan 31
| |||||||
Akebia Therapeutics, Inc.
| 223.95K |
—
|
—
|
∞
| 223.95K |
Jan 31
| |||||||
Akebia Therapeutics, Inc.
| 149.3K |
—
|
—
| +25.87% | 726.34K | +1 |
Jan 31
| ||||||
Akebia Therapeutics, Inc.
| 149.3K |
—
|
—
| +40.35% | 519.3K | +1 |
Jan 31
| ||||||
Akebia Therapeutics, Inc.
| 149.3K |
—
|
—
| +28.31% | 676.64K | +1 |
Jan 31
| ||||||
Akebia Therapeutics, Inc.
| 557.01K |
$1.68 | -$78,101.52 | +35.44% | 2.13M |
Jan 31 - Feb 1
| |||||||
Akebia Therapeutics, Inc.
| 177.89K |
$1.68 | -$40,842.48 | +33.34% | 711.38K | +1 |
Jan 31 - Feb 1
| ||||||
Akebia Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Akebia Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Akebia Therapeutics, Inc.
| 370K |
—
|
—
|
∞
| 370K | +1 |
Jul 31
| ||||||
Akebia Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +218.98% | 43.7K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +45.43% | 96.03K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +218.98% | 43.7K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +79.62% | 67.68K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +28.63% | 134.8K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +45.99% | 95.23K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 30K |
—
|
—
| +52.51% | 87.13K |
Jun 6
| |||||||
Akebia Therapeutics, Inc.
| 136.81K |
$1.22 | -$77,270.16 | +35.30% | 524.34K | +1 |
May 24 - May 25
| ||||||
Akebia Therapeutics, Inc.
| 104.52K |
$1.22 | -$116,760.05 | +22.26% | 574.04K | +1 |
May 24 - May 25
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.